Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells

Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J. Pathol., 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Yee, 1985, Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines, Am. J. Pathol., 119, 361 Rocha-Zavaleta, 2004, Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer, Cell. Signal., 16, 1239, 10.1016/j.cellsig.2004.03.011 Lagunas-Cruz, 2019, IL-2 induces transient arrest in the G1 phase to protect cervical cancer cells from entering apoptosis, J Oncol., 2019, 7475295, 10.1155/2019/7475295 Herrera-Miranda, 2012 Mindiola, 2008, Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix, Invest. Clin., 49, 533 R. Rangel-Corona, L. Rodríguez-Cruz, G. Flores-Flores, C. Gómez-Ruiz, I. Soto-Cruz, F. Mendoza-Rincón, et al., Differential expression of the two components of the interleukin-2 receptor in cervical cancer cells, in: Monduzzi, M. Moraes, R. Brentani, R. Bevlacqua (Eds.). Proceedings of the 17th International Cancer Congress; 1998; Rio de Janeiro, Brazil, pp. 1239–1243. ISBN 9788832308242. Boyman, 2012, The role of interleukin-2 during homeostasis and activation of the immune system, Nat. Rev. Immunol., 12, 180, 10.1038/nri3156 Wang, 2005, Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors, Science, 310, 1159, 10.1126/science.1117893 Valle-Mendiola, 2014, IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects, Cancer Invest., 32, 115, 10.3109/07357907.2014.883526 Harel-Bellan, 1986, Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation, J. Immunol., 136, 2463, 10.4049/jimmunol.136.7.2463 Valle-Mendiola, 2016, Pleiotropic effects of IL-2 on cancer: its role in cervical cancer, Mediators Inflamm., 2016, 2849523, 10.1155/2016/2849523 de Jong, 2004, Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6, Cancer Res., 64, 5449, 10.1158/0008-5472.CAN-04-0831 Barros, 2018, Viral modulation of TLRs and cytokines and the related immunotherapies for HPV-associated cancers, J. Immunol. Res., 2018, 2912671, 10.1155/2018/2912671 Westrich, 2017, Evasion of host immune defenses by human papillomavirus, Virus Res., 231, 21, 10.1016/j.virusres.2016.11.023 Torres, 1993, HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix, Tissue Antigens, 41, 65, 10.1111/j.1399-0039.1993.tb01981.x Gameiro, 2017, Analysis of class I major histocompatibility complex gene transcription in human tumors caused by human papillomavirus infection, Viruses, 9, 252, 10.3390/v9090252 Cho, 2001, Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18, FEBS Lett., 501, 139, 10.1016/S0014-5793(01)02652-7 Tindle, 2002, Immune evasion in human papillomavirus-associated cervical cancer, Nat. Rev. Cancer, 2, 59, 10.1038/nrc700 Nees, 2001, Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes, J. Virol., 75, 4283, 10.1128/JVI.75.9.4283-4296.2001 Richards, 2014, Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes, J. Virol., 88, 4173, 10.1128/JVI.02546-13 Torres-Poveda, 2014, Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia, World J Clin Oncol., 5, 753, 10.5306/wjco.v5.i4.753 Xue, 2018, Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk human papillomavirus infection, Cancer Med., 7, 297, 10.1002/cam4.1279 Schwarz, 1985, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, 314, 111, 10.1038/314111a0 Caceres-Cortes, 2001, Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias, Cancer Res., 61, 6281 Mora-García, 2017, Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway, Cell. Immunol., 320, 46, 10.1016/j.cellimm.2017.09.002 J. Sambrook, D.W. Russell, Molecular Cloning: A Laboratory Manual, third ed., in: C.S. Harbor (Ed.), Cold Spring Harbor Laboratory Press, New York, NY, USA, 2001. Halbert, 1991, The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells, J. Virol., 65, 473, 10.1128/jvi.65.1.473-478.1991 Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2 Rochman, 2009, New insights into the regulation of T cells by gamma(c) family cytokines, Nat. Rev. Immunol., 9, 480, 10.1038/nri2580 Malek, 2010, Interleukin-2 receptor signaling: at the interface between tolerance and immunity, Immunity, 32, 153, 10.1016/j.immuni.2010.08.004 Rangel-Corona, 2010, Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor, Cytokine, 50, 273, 10.1016/j.cyto.2010.02.013 Narisawa-Saito, 2007, Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins, Cancer Sci., 98, 1505, 10.1111/j.1349-7006.2007.00546.x Durzynska, 2017, Human papillomaviruses in epigenetic regulations, Mutat. Res. Rev. Mutat. Res., 772, 36, 10.1016/j.mrrev.2016.09.006 Songock, 2017, The human papillomavirus E7 oncoprotein as a regulator of transcription, Virus Res., 231, 56, 10.1016/j.virusres.2016.10.017 Reinecker, 1995, Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor, Proc. Natl. Acad. Sci. U.S.A., 92, 8353, 10.1073/pnas.92.18.8353 Gruss, 1996, Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1, J. Immunol., 157, 851, 10.4049/jimmunol.157.2.851 Rimoldi, 1993, Expression of IL-2 receptors in human melanoma cells, Anticancer Res., 13, 555 Yasumura, 1994, Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2, Int. J. Cancer, 59, 225, 10.1002/ijc.2910590215 Kuhn, 2005, The role of interleukin-2 receptor alpha in cancer, Front Biosci., 10, 1462, 10.2741/1631 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Shah, 2011, A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix, Cell. Mol. Immunol., 8, 59, 10.1038/cmi.2010.56 Yu, 2006, Tumor-infiltrating T lymphocytes: friends or foes?, Lab. Invest., 86, 231, 10.1038/labinvest.3700389 Radvanyi, 2012, Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients, Clin. Cancer Res., 18, 6758, 10.1158/1078-0432.CCR-12-1177 Trentin, 1994, Functional role of IL-2 receptors on tumour-infiltrating lymphocytes, Br. J. Cancer, 69, 1046, 10.1038/bjc.1994.206 Rangel, 1995, Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-γ, and TNF-α with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture, Eur. Cytokine Netw., 6, 195 Rangel-Corona, 2011, Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cells in vitro, and significantly reduced tumor burden in immunodepressed mice, J. Drug Target., 19, 79, 10.3109/10611861003733920